279 related articles for article (PubMed ID: 19855356)
1. Oxytocin and carbetocin effects on spontaneous behavior of male rats: modulation by oxytocin receptor antagonists.
Klenerova V; Krejci I; Sida P; Hlinak Z; Hynie S
Neuro Endocrinol Lett; 2009; 30(3):335-42. PubMed ID: 19855356
[TBL] [Abstract][Full Text] [Related]
2. Modulary effects of oxytocin and carbetocin on stress-induced changes in rat behavior in the open-field.
Klenerova V; Krejci I; Sida P; Hlinak Z; Hynie S
J Physiol Pharmacol; 2009 Jun; 60(2):57-62. PubMed ID: 19617646
[TBL] [Abstract][Full Text] [Related]
3. Oxytocin and carbetocin ameliorating effects on restraint stress-induced short- and long-term behavioral changes in rats.
Klenerova V; Krejci I; Sida P; Hlinak Z; Hynie S
Neuro Endocrinol Lett; 2010; 31(5):622-30. PubMed ID: 21173744
[TBL] [Abstract][Full Text] [Related]
4. Effects of melanotan II, a melanocortin agonist, on grooming and exploration in rats after repeated restraint/immobilization.
Klenerová V; Krejcí I; Sída P; Hlinák Z; Hynie S
Neurosci Lett; 2008 Feb; 432(3):202-5. PubMed ID: 18191328
[TBL] [Abstract][Full Text] [Related]
5. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
[TBL] [Abstract][Full Text] [Related]
6. Galanin modulating effect on restraint stress-induced short- and long-term behavioral changes in Wistar rats.
Klenerova V; Flegel M; Skopek P; Sida P; Hynie S
Neurosci Lett; 2011 Sep; 502(3):147-51. PubMed ID: 21763401
[TBL] [Abstract][Full Text] [Related]
7. Simple behavioral measures of central alpha-adrenoceptor blocking activity of drugs.
Delini-Stula A
Pol J Pharmacol Pharm; 1984; 36(5):513-21. PubMed ID: 6152494
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent effects of caffeine on behavior and thermoregulation in a chronic unpredictable stress model of depression in rats.
Pechlivanova D; Tchekalarova J; Nikolov R; Yakimova K
Behav Brain Res; 2010 Jun; 209(2):205-11. PubMed ID: 20122970
[TBL] [Abstract][Full Text] [Related]
9. Behavioral characterization of morphine effects on motor activity in mice.
Patti CL; Frussa-Filho R; Silva RH; Carvalho RC; Kameda SR; Takatsu-Coleman AL; Cunha JL; Abílio VC
Pharmacol Biochem Behav; 2005 Aug; 81(4):923-7. PubMed ID: 16083952
[TBL] [Abstract][Full Text] [Related]
10. Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') using a drug discrimination paradigm in the rat.
Broadbear JH; Tunstall B; Beringer K
Addict Biol; 2011 Apr; 16(2):202-14. PubMed ID: 21070509
[TBL] [Abstract][Full Text] [Related]
11. Effect of a benzodiazepine receptor agonist and corticotropin-releasing hormone receptor antagonists on long-term foot-shock-induced increase in defensive withdrawal behavior.
Bruijnzeel AW; Stam R; Wiegant VM
Psychopharmacology (Berl); 2001 Nov; 158(2):132-9. PubMed ID: 11702086
[TBL] [Abstract][Full Text] [Related]
12. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Nakazato A; Kumagai T; Okubo T; Tomisawa K
J Pharmacol Exp Ther; 1999 May; 289(2):926-35. PubMed ID: 10215672
[TBL] [Abstract][Full Text] [Related]
13. Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field.
de Souza Silva MA; Topic B; Huston JP; Mattern C
Synapse; 2008 Mar; 62(3):176-84. PubMed ID: 18081176
[TBL] [Abstract][Full Text] [Related]
14. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
[TBL] [Abstract][Full Text] [Related]
15. Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat.
Mak P; Broussard C; Vacy K; Broadbear JH
J Psychopharmacol; 2012 Apr; 26(4):532-42. PubMed ID: 21890582
[TBL] [Abstract][Full Text] [Related]
16. Neuroanatomical and cellular substrates of hypergrooming induced by microinjection of oxytocin in central nucleus of amygdala, an experimental model of compulsive behavior.
Marroni SS; Nakano FN; Gati CD; Oliveira JA; Antunes-Rodrigues J; Garcia-Cairasco N
Mol Psychiatry; 2007 Dec; 12(12):1103-17. PubMed ID: 17505467
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin decreases corticosterone and nociception and increases motor activity in OVX rats.
Petersson M; Eklund M; Uvnäs-Moberg K
Maturitas; 2005 Aug; 51(4):426-33. PubMed ID: 16039417
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and neurochemical profile of m-CPP following exposure to single restraint stress in rat.
Samad N; Haleem DJ
Acta Neurol Belg; 2009 Mar; 109(1):24-31. PubMed ID: 19402569
[TBL] [Abstract][Full Text] [Related]
19. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and neurochemical effects on rat offspring after prenatal exposure to ethanol.
Carneiro LM; Diógenes JP; Vasconcelos SM; Aragão GF; Noronha EC; Gomes PB; Viana GS
Neurotoxicol Teratol; 2005; 27(4):585-92. PubMed ID: 16039829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
